FDA Inspection 1270208 — Exel Inc.
The FDA completed an inspection of Exel Inc. on September 25, 2025 in Manchester, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 25, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Manchester, PA (United States)